文章摘要
郑艳秋 胡文良△ 崔晓波 孙学威 王亚平 孙源昊.CDC42 抑制剂ML141对喉癌Hep-2 细胞增殖的抑制作用[J].,2016,16(4):644-646
CDC42 抑制剂ML141对喉癌Hep-2 细胞增殖的抑制作用
CDC42 Inhibitor ML141 Suppresses Laryngeal Cancer Hep-2 CellProliferation
  
DOI:
中文关键词: 喉癌  CDC42  ML141  细胞增殖
英文关键词: Laryngweal cancer  CDC42  ML141  Cell proliferation
基金项目:内蒙古自治区自然科学基金项目(2014MS0856);内蒙古医科大学科技百万工程项目(KJbw2013014)
作者单位
郑艳秋 胡文良△ 崔晓波 孙学威 王亚平 孙源昊 内蒙古医科大学附属医院耳鼻咽喉科 
摘要点击次数: 824
全文下载次数: 0
中文摘要:
      目的:探讨CDC42 抑制剂ML141 对喉癌细胞增殖的抑制作用,为喉癌的分子治疗提供新的靶点。方法:体外培养人喉癌 Hep-2细胞。实时定量聚合酶链反应(Real-time PCR)检测CDC42 在Hep-2细胞中的表达。利用GLISA 法检测ML141 对CDC42 活性的抑制效果。利用CCK8 法检测ML141 对Hep-2 细胞增殖能力的抑制效果。结果:①Real-time PCR 结果显示在人喉癌 Hep-2 细胞中CDC42 显著高表达(P<0.001),证明全基因组的结果准确。②GLISA 结果显示表皮生长因子作用的Hep-2细胞中 CDC42 的活性明显高表达,但加入ML141的Hep-2细胞中CDC42 的活性受到明显抑制。(P<0.001)。③CCK8 结果显示24 h,48 h和72 h时,ML141 处理的Hep-2 细胞的增殖能力与对照组相比均受到明显抑制。(P<0.001)。结论:促癌基因CDC42 抑制剂 ML141 能够抑制人喉癌Hep-2 细胞增殖,具有成为抗喉癌新药的潜力,为喉癌的分子治疗提供新的切入点。
英文摘要:
      Objective:Investigating the effect of CDC42 inhibitor ML141 on Hep-2 cell proliferation to provide new targets for molecular therapy of laryngeal.Methods:Hep-2 cells were cultured in vitro. Real-time PCR was used to identify the expression of CDC42 in Hep-2 cell. GLISA was carried out to detect the changes in activation of CDC42 in Hep-2 cell treated with ML141. CCK8 assay was used to detect the effect of ML141 on Hep-2 cell proliferation.Results:① The result of Real-time PCR showed that CDC42 gene was differentially expressed in Hep-2 cells, which consistent with the results of the whole genome profiling (P<0.001). ②The result of GLISA showed that EGF can increase the activation of CDC42 in Hep-2 cell but ML141 can inhibit its activation significantly. (p<0. 001). ③The result of CCK8 showed that the proliferation of Hep-2 cell was significantly inhibited by treating with ML141 after 24 h, 48 h and 72 h compared with control group(P<0.001).Conclusion:CDC42 inhibitor ML141 can inhibit the proliferation of Hep-2 cell. ML141 may have the potential to become the new anti-cancer drug, which provided a new target point for molecular therapy of laryngeal cancer.
查看全文   查看/发表评论  下载PDF阅读器
关闭